In the early 2000s, the prevalence of diabetes in adults aged ≥30 years in Korea was about 9% to 10%, and it remained stable. However, a nationwide survey showed that this prevalence increased over the past few years. After age-standardization using the Korean population of the year 2010, the prevalence of diabetes in adults aged ≥30 years was 10.0% to 10.8% between 2001 and 2012, which increased to 12.5% in 2013 and 11.6% in 2014. During that period, there have been changes in the gender- and age-specific prevalence of diabetes in Korean adults. The prevalence of diabetes in the elderly population increased significantly, while this prevalence in young adults, especially in young women, did not change significantly. The contribution of each diabetic risk factor, such as obesity, β-cell dysfunction, sarcopenia, and socioeconomic status, in developing diabetes has also changed during that period in each gender and age group. For young women, obesity was the most important risk factor; by contrast, for elderly diabetic patients, sarcopenia was more important than obesity as a risk factor. Considering the economic burden of diabetes and its associated comorbidities, a public health policy targeting the major risk factors in each population might be more effective in preventing diabetes.

Citations

Citations to this article as recorded by  

• Real-World Outcomes of Individualized Targeted Therapy with Insulin Glargine 300 Units/mL in Insulin-Naïve Korean People with Type 2 Diabetes: TOBE Study
  Eun-Gyoung Hong, Kyung-Wan Min, Jung Soo Lim, Kyu-Jeung Ahn, Chul Woo Ahn, Jae-Myung Yu, Hye Soon Kim, Hyun Jin Kim, Won Kim, Dong Han Kim, Hak Chul Jang
  Advances in Therapy.2024; 41(5): 1967.     CrossRef
• Plasma glucose levels and diabetes are independent predictors for mortality in patients with COVID-19
  Hui Long, Jiachen Li, Rui Li, Haiyang Zhang, Honghan Ge, Hui Zeng, Xi Chen, Qingbin Lu, Wanli Jiang, Haolong Zeng, Tianle Che, Xiaolei Ye, Liqun Fang, Ying Qin, Qiang Wang, Qingming Wu, Hao Li, Wei Liu
  Epidemiology and Infection.2022;[Epub]     CrossRef
• Type 2 Diabetes Mellitus with Early Dry Skin Disorder: A Comparison Study Between Primary and Tertiary Care in Indonesia
  Lili Legiawati, Kusmarinah Bramono, Wresti Indriatmi, Em Yunir, Aditya Indra Pratama
  Current Diabetes Reviews.2022;[Epub]     CrossRef
• Physical Comorbidity According to Diagnoses and Sex among Psychiatric Inpatients in South Korea
  Suin Park, Go-Un Kim, Hyunlye Kim
  International Journal of Environmental Research and Public Health.2021; 18(8): 4187.     CrossRef
• Muscle strength, an independent determinant of glycemic control in older adults with long-standing type 2 diabetes: a prospective cohort study
  Bo Kyung Koo, Seoil Moon, Min Kyong Moon
  BMC Geriatrics.2021;[Epub]     CrossRef
• Site-specific cancer risk in patients with type 2 diabetes: a nationwide population-based cohort study in Korea
  Suk Kyeong Kim, Ju-Young Jang, Dong-Lim Kim, Young A Rhyu, Suh Eun Lee, Seung-Hyun Ko, Kyungdo Han, Kee-Ho Song
  The Korean Journal of Internal Medicine.2020; 35(3): 641.     CrossRef
• Hypoglycemic efficacy and safety of Momordica charantia (bitter melon) in patients with type 2 diabetes mellitus
  Soo Kyoung Kim, Jaehoon Jung, Jung Hwa Jung, NalAe Yoon, Sang Soo Kang, Gu Seob Roh, Jong Ryeal Hahm
  Complementary Therapies in Medicine.2020; 52: 102524.     CrossRef
• Taking metformin and cognitive function change in older patients with diabetes
  Bo Kyung Koo, Lee‐Kyung Kim, Jun‐Young Lee, Min Kyong Moon
  Geriatrics & Gerontology International.2019; 19(8): 755.     CrossRef
• Trends in Diabetes Prevalence, Awareness, Treatment and Control in Yangon Region, Myanmar, Between 2004 and 2014, Two Cross-Sectional Studies
  Wai Phyo Aung, Espen Bjertness, Aung Soe Htet, Hein Stigum, Marte Karoline Råberg Kjøllesdal
  International Journal of Environmental Research and Public Health.2019; 16(18): 3461.     CrossRef
• Validity of Japanese version of SARC‐F questionnaire in patients with chronic liver disease
  Satoshi Ida, Yuji Kojima, Shima Hamaoka, Naohito Urawa, Jun Araki, Ryutaro Kaneko, Kazuya Murata
  Journal of Gastroenterology and Hepatology.2019; 34(5): 947.     CrossRef
• Letter: Projection of Diabetes Prevalence in Korean Adults for the Year 2030 Using Risk Factors Identified from National Data (Diabetes Metab J 2019;43:90–6)
  Bo Kyung Koo
  Diabetes & Metabolism Journal.2019; 43(2): 242.     CrossRef
• Antidiabetic Effects of Vigna nakashimae Extract in Humans: A Preliminary Study
  Soo Kyoung Kim, Jaehoon Jung, Jung Hwa Jung, Byong Won Lee, Sang Soo Kang, Gu Seob Roh, Jong Ryeal Hahm
  The Journal of Alternative and Complementary Medicine.2018; 24(3): 249.     CrossRef
• Serum Betatrophin Concentrations and the Risk of Incident Diabetes: A Nested Case-Control Study from Chungju Metabolic Disease Cohort
  Seung-Hwan Lee, Marie Rhee, Hyuk-Sang Kwon, Yong-Moon Park, Kun-Ho Yoon
  Diabetes & Metabolism Journal.2018; 42(1): 53.     CrossRef
• Relationship between age and cardiometabolic index in Japanese men and women
  Ichiro Wakabayashi
  Obesity Research & Clinical Practice.2018; 12(4): 372.     CrossRef
• Kidney transplantation in patients with diabetes: better than nothing
  Chang Seong Kim
  The Korean Journal of Internal Medicine.2018; 33(2): 293.     CrossRef
• The Changes of Macular Microvasculature and Related Systemic Parameters in Diabetic Patients without Diabetic Retinopathy
  Sang Wook Choi, Joon Hee Cho, Ha Kyung Kim, So Hyun Bae
  Journal of the Korean Ophthalmological Society.2017; 58(7): 811.     CrossRef
• Dietary total, animal, vegetable calcium and type 2 diabetes incidence among Korean adults: The Korean Multi-Rural Communities Cohort (MRCohort)
  J.M. Oh, H.W. Woo, M.K. Kim, Y.-H. Lee, D.H. Shin, M.-H. Shin, B.Y. Choi
  Nutrition, Metabolism and Cardiovascular Diseases.2017; 27(12): 1152.     CrossRef
• The Influence of Prenatal Exercise on Offspring Health: A Review
  Carmen Moyer, Olga Roldan Reoyo, Linda May
  Clinical Medicine Insights: Women's Health.2016; 9: CMWH.S34670.     CrossRef

Populations are aging and the prevalence of diabetes mellitus is increasing tremendously. The number of older people with diabetes is increasing unexpectedly. Aging and diabetes are both risk factors for functional disability. Thus, increasing numbers of frail or disabled older patients with diabetes will increase both direct and indirect health-related costs. Diabetes has been reported as an important risk factor of developing physical disability in older adults. Older people with diabetes have lower muscle mass and weaker muscle strength. In addition, muscle quality is poorer in diabetic patients. Sarcopenia and frailty have a common soil and may share a similar pathway for multiple pathologic processes in older people. Sarcopenia is thought to be an intermediate step in the development of frailty in patients with diabetes. Thus, early detection of sarcopenia and frailty in older adults with diabetes should be routine clinical practice to prevent frailty or to intervene earlier in frail patients.

Citations

Citations to this article as recorded by  

• Glycemic control and prescription profiles in internal medicine inpatients: The role of frailty
  Jose Carlos Arévalo Lorido, Juana Carretero Gomez, Patricia Vazquez Rodriguez, Ricardo Gómez Huelgas, Carmen Marín Silvente, Fernando Javier Sánchez Lora, Elena Isaba Ares, Anna Pardo i Pelegrín, Onán Pérez Hernández, Javier Ena
  European Journal of Internal Medicine.2024; 121: 103.     CrossRef
• Prolonged hospitalization and 1-year mortality are associated with sarcopenia and malnutrition in older patients with type 2 diabetes: A prospective cohort study
  Mileni Vanti Beretta, Tatiana Pedroso de Paula, Ticiana da Costa Rodrigues, Thais Steemburgo
  Diabetes Research and Clinical Practice.2024; 207: 111063.     CrossRef
• The role of genes and myokines of developing sarcopenia: A review
  Farida V. Valeeva, Zhanna A. Rodygina, Tatyana S. Yilmaz
  Consilium Medicum.2024; 26(4): 219.     CrossRef
• Effect of Frailty on Depression among Patients with Late-life Depression: A Test of Anger, Anxiety, and Resilience as Mediators
  Junhyung Kim, Hyun-Ghang Jeong, Moon-Soo Lee, Chi-Un Pae, Ashwin A. Patkar, Sang Won Jeon, Cheolmin Shin, Changsu Han
  Clinical Psychopharmacology and Neuroscience.2024; 22(2): 253.     CrossRef
• Relationship Between Frailty and Diabetic Pharmacologic Therapy in Older Adults with Type 2 Diabetes: A Cross-Sectional Study
  Akiko Nishimura, Chie Masuda, Chiyo Murauchi, Miho Ishii, Yuko Murata, Terumi Kawasaki, Mayumi Azuma, Shin-ichi Harashima
  Drugs & Aging.2024;[Epub]     CrossRef
• Urgent needs of caregiving in ageing populations with Alzheimer’s disease and other chronic conditions: Support our loved ones
  John W. Culberson, Jonathan Kopel, Ujala Sehar, P. Hemachandra Reddy
  Ageing Research Reviews.2023; 90: 102001.     CrossRef
• Hand grip strength: A reliable assessment tool of frailty status on the person with type 2 diabetes mellitus
  Diogo Ramalho, Leonor Silva, Catarina Almeida, Luís Rocha, Gustavo Rocha, Rafaela Veríssimo
  Nutrition Clinique et Métabolisme.2023; 37(1): 45.     CrossRef
• Comprehensive review: Frailty in pancreas transplant candidates and recipients
  Ronald F. Parsons, Ekamol Tantisattamo, Wisit Cheungpasitporn, Arpita Basu, Yee Lu, Krista L. Lentine, Kenneth J. Woodside, Neeraj Singh, Joseph Scalea, Tarek Alhamad, Ty B. Dunn, Franco H. Cabeza Rivera, Sandesh Parajuli, Martha Pavlakis, Matthew Cooper
  Clinical Transplantation.2023;[Epub]     CrossRef
• Development and validation of a risk prediction model for frailty in patients with diabetes
  Fan Bu, Xiao-hui Deng, Na-ni Zhan, Hongtao Cheng, Zi-lin Wang, Li Tang, Yu Zhao, Qi-yuan Lyu
  BMC Geriatrics.2023;[Epub]     CrossRef
• Amino Acid Profiles in Older Adults with Frailty: Secondary Analysis from MetaboFrail and BIOSPHERE Studies
  Riccardo Calvani, Anna Picca, Leocadio Rodriguez-Mañas, Matteo Tosato, Hélio José Coelho-Júnior, Alessandra Biancolillo, Olga Laosa, Jacopo Gervasoni, Aniello Primiano, Lavinia Santucci, Ottavia Giampaoli, Isabelle Bourdel-Marchasson, Sophie C. Regueme, A
  Metabolites.2023; 13(4): 542.     CrossRef
• Where to Start? Physical Assessment, Readiness, and Exercise Recommendations for People With Type 1 or Type 2 Diabetes
  Marni Armstrong, Sheri R. Colberg, Ronald J. Sigal
  Diabetes Spectrum.2023; 36(2): 105.     CrossRef
• The Association Between Sarcopenia and Diabetes: From Pathophysiology Mechanism to Therapeutic Strategy
  Huiling Chen, Xiaojing Huang, Meiyuan Dong, Song Wen, Ligang Zhou, Xinlu Yuan
  Diabetes, Metabolic Syndrome and Obesity.2023; Volume 16: 1541.     CrossRef
• Analysis of Individual Components of Frailty in Simultaneous Pancreas and Kidney, and Solitary Pancreas Transplant Recipients
  Sandesh Parajuli, Jon Odorico, Isabel Breyer, Emily Zona, Fahad Aziz, Heather Lorden, Jacqueline Garonzik-Wang, Dixon Kaufman, Didier Mandelbrot
  Transplantation Direct.2023; 9(9): e1523.     CrossRef
• Effects of moderate exercise versus light exercise on fasting blood glucose in obese patients with type 2 diabetes mellitus
  Manal Kamel Youssef
  Physiotherapy Quarterly.2023; 31(3): 101.     CrossRef
• Risk factors associated with frailty in older adults with type 2 diabetes: A cross‐sectional study
  Chia‐Ling Lin, Neng‐Chun Yu, Hsueh‐Ching Wu, Yuan‐Ching Liu
  Journal of Clinical Nursing.2022; 31(7-8): 967.     CrossRef
• Sarcopenia in patients with multiple sclerosis
  Hatice Yuksel, Mehtap Balaban, Ozlem Ozturk Tan, Semra Mungan
  Multiple Sclerosis and Related Disorders.2022; 58: 103471.     CrossRef
• Amino acid profile of skeletal muscle loss in type 2 diabetes: Results from a 7-year longitudinal study in asians
  Serena Low, Jiexun Wang, Angela Moh, Su Fen Ang, Keven Ang, Yi-Ming Shao, Jianhong Ching, Hai Ning Wee, Lye Siang Lee, Jean-Paul Kovalik, Wern Ee Tang, Ziliang Lim, Tavintharan Subramaniam, Chee Fang Sum, Su Chi Lim
  Diabetes Research and Clinical Practice.2022; 186: 109803.     CrossRef
• Assessment of Muscle Quantity, Quality and Function
  Bo Kyung Koo
  Journal of Obesity & Metabolic Syndrome.2022; 31(1): 9.     CrossRef
• Sarcopenia is associated with cardiovascular risk in men with COPD, independent of adiposity
  Ah Young Leem, Young Sam Kim, Kung Soo Chung, Moo Suk Park, Young Ae Kang, Young-Mok Park, Ji Ye Jung
  Respiratory Research.2022;[Epub]     CrossRef
• Decline in skeletal muscle mass is associated with cognitive decline in type 2 diabetes mellitus
  Serena Low, Kiat Sern Goh, Tze Pin Ng, Angela Moh, Su Fen Ang, Jonathon Khoo, Keven Ang, Philip Yap, Chin Yee Cheong, Wern Ee Tang, Ziliang Lim, Tavintharan Subramaniam, Chee Fang Sum, Su Chi Lim
  Journal of Diabetes and its Complications.2022; 36(9): 108258.     CrossRef
• Frailty and diabetes in older adults: Overview of current controversies and challenges in clinical practice
  Mohd Zaquan Arif Abd.Ghafar, Mark O’Donovan, Duygu Sezgin, Elizabeth Moloney, Ángel Rodríguez-Laso, Aaron Liew, Rónán O’Caoimh
  Frontiers in Clinical Diabetes and Healthcare.2022;[Epub]     CrossRef
• Implications of the Metabolic Control of Diabetes in Patients with Frailty Syndrome
  Marta Muszalik, Hubert Stępień, Grażyna Puto, Mateusz Cybulski, Donata Kurpas
  International Journal of Environmental Research and Public Health.2022; 19(16): 10327.     CrossRef
• Protective Effect of Delta-Like 1 Homolog Against Muscular Atrophy in a Mouse Model
  Ji Young Lee, Minyoung Lee, Dong-Hee Lee, Yong-ho Lee, Byung-Wan Lee, Eun Seok Kang, Bong-Soo Cha
  Endocrinology and Metabolism.2022; 37(4): 684.     CrossRef
• Diabetes and osteoporosis – Treating two entities: A challenge or cause for concern?
  Nicklas H. Rasmussen, Peter Vestergaard
  Best Practice & Research Clinical Rheumatology.2022; 36(3): 101779.     CrossRef
• Predictors associated with prefrailty in older Taiwanese individuals with type 2 diabetes
  Shu-Fen Lee, Chih-Ping Li, Yen-Lin Chen, Dee Pei
  Medicine.2022; 101(38): e30432.     CrossRef
• Association of walking speed with cognitive function in Chinese older adults: A nationally representative cohort study
  Jianping Liu, Kaiwang Cui, Qian Chen, Zhiteng Li, Jing Fu, Xiangwen Gong, Hui Xu
  Frontiers in Aging Neuroscience.2022;[Epub]     CrossRef
• Lower insulin level is associated with sarcopenia in community-dwelling frail and non-frail older adults
  Yanxia Lu, Wee Shiong Lim, Xia Jin, Ma Schwe Zin Nyunt, Tamas Fulop, Qi Gao, Su Chi Lim, Anis Larbi, Tze Pin Ng
  Frontiers in Medicine.2022;[Epub]     CrossRef
• Weight-adjusted waist index reflects fat and muscle mass in the opposite direction in older adults
  Nam Hoon Kim, Yousung Park, Nan Hee Kim, Sin Gon Kim
  Age and Ageing.2021; 50(3): 780.     CrossRef
• Examining the links between regular leisure‐time physical activity, sitting time and prefrailty in community‐dwelling older adults
  Shu‐Hung Chang, Nai‐Hui Chien, Jackson Pui‐Man Wai, Ching‐Cheng Chiang, Ching‐Yi Yu
  Journal of Advanced Nursing.2021; 77(6): 2761.     CrossRef
• Tale of the Frail: Understanding Frailty in Cirrhosis
  Faruq Pradhan, Natasha Narang, Michael Fallon
  Southern Medical Journal.2021; 114(3): 186.     CrossRef
• Type 2 diabetes mellitus in older adults: clinical considerations and management
  Srikanth Bellary, Ioannis Kyrou, James E. Brown, Clifford J. Bailey
  Nature Reviews Endocrinology.2021; 17(9): 534.     CrossRef
• Low Protein Intakes and Poor Diet Quality Associate with Functional Limitations in US Adults with Diabetes: A 2005–2016 NHANES Analysis
  Stephanie M. Fanelli, Owen J. Kelly, Jessica L. Krok-Schoen, Christopher A. Taylor
  Nutrients.2021; 13(8): 2582.     CrossRef
• Yaşlı Diyabetik Hastalarda Malnutrisyonun Klinik Sonuçları ve Önemi
  Saadet KOÇ OKUDUR, Pinar SOYSAL
  OSMANGAZİ JOURNAL OF MEDICINE.2021;[Epub]     CrossRef
• Combined Aerobic and Resistance Exercise Training Reduces Circulating Apolipoprotein J Levels and Improves Insulin Resistance in Postmenopausal Diabetic Women
  Yun Kyung Jeon, Sang Soo Kim, Jong Ho Kim, Hyun Jeong Kim, Hyun Jun Kim, Jang Jun Park, Yuen Suk Cho, So Hee Joung, Ji Ryang Kim, Bo Hyun Kim, Sang Heon Song, In Joo Kim, Yong Ki Kim, Young-Bum Kim
  Diabetes & Metabolism Journal.2020; 44(1): 103.     CrossRef
• Effects of elastic band exercise on the frailty states in pre-frail elderly people
  Rujie Chen, Qingwen Wu, Dongyan Wang, Zhou Li, Howe Liu, Guangtian Liu, Ying Cui, Linlin Song
  Physiotherapy Theory and Practice.2020; 36(9): 1000.     CrossRef
• Association between Lower Extremity Skeletal Muscle Mass and Impaired Cognitive Function in Type 2 Diabetes
  Serena Low, Tze Pin Ng, Chin Leong Lim, Angela Moh, Su Fen Ang, Jiexun Wang, Kiat Sern Goh, Keven Ang, Wern Ee Tang, Pek Yee Kwan, Tavintharan Subramaniam, Chee Fang Sum, Su Chi Lim
  Scientific Reports.2020;[Epub]     CrossRef
• Low free triiodothyronine levels are associated with risk of frailty in older adults with type 2 diabetes mellitus
  Shuangling Xiu, Zhijing Mu, Lei Zhao, Lina Sun
  Experimental Gerontology.2020; 138: 111013.     CrossRef
• The Biomechanics of Diabetes Mellitus and Limb Preservation
  Jonathan M. Labovitz, Dana Day
  Clinics in Podiatric Medicine and Surgery.2020; 37(1): 151.     CrossRef
• Inorganic Arsenic Exposure Decreases Muscle Mass and Enhances Denervation-Induced Muscle Atrophy in Mice
  Chang-Mu Chen, Min-Ni Chung, Chen-Yuan Chiu, Shing-Hwa Liu, Kuo-Cheng Lan
  Molecules.2020; 25(13): 3057.     CrossRef
• Physical Exercise and Myokines: Relationships with Sarcopenia and Cardiovascular Complications
  Sandra Maria Barbalho, Uri Adrian Prync Flato, Ricardo José Tofano, Ricardo de Alvares Goulart, Elen Landgraf Guiguer, Cláudia Rucco P. Detregiachi, Daniela Vieira Buchaim, Adriano Cressoni Araújo, Rogério Leone Buchaim, Fábio Tadeu Rodrigues Reina, Piero
  International Journal of Molecular Sciences.2020; 21(10): 3607.     CrossRef
• The relationships between sarcopenic skeletal muscle loss during ageing and macronutrient metabolism, obesity and onset of diabetes
  Ailsa A. Welch, Richard P. G. Hayhoe, Donnie Cameron
  Proceedings of the Nutrition Society.2020; 79(1): 158.     CrossRef
• Effects of low skeletal muscle mass and sarcopenic obesity on albuminuria: a 7-year longitudinal study
  Jee Hee Yoo, Gyuri Kim, Sung Woon Park, Min Sun Choi, Jiyeon Ahn, Sang-Man Jin, Kyu Yeon Hur, Moon-Kyu Lee, Mira Kang, Jae Hyeon Kim
  Scientific Reports.2020;[Epub]     CrossRef
• Sarcopenia, nutritional status and type 2 diabetes mellitus: A cross‐sectional study in a group of Mexican women residing in a nursing home
  María C. Velázquez‐Alva, María E. Irigoyen‐Camacho, Marco A. Zepeda‐Zepeda, Irina Lazarevich, Isabel Arrieta‐Cruz, Carlos D'Hyver
  Nutrition & Dietetics.2020; 77(5): 515.     CrossRef
• Assessing the association between optimal energy intake and all‐cause mortality in older patients with diabetes mellitus using the Japanese Elderly Diabetes Intervention Trial
  Takuya Omura, Yoshiaki Tamura, Takuya Yamaoka, Yukio Yoshimura, Takashi Sakurai, Hiroyuki Umegaki, Chiemi Kamada, Satoshi Iimuro, Yasuo Ohashi, Hideki Ito, Atsushi Araki
  Geriatrics & Gerontology International.2020; 20(1): 59.     CrossRef
• Sarkopenie im Kontext von Insulinresistenz und Diabetes mellitus im Alter – Daten aus der Berliner Altersstudie II
  Dominik Spira, Nikolaus Buchmann, Knut Mai, Thomas Bobbert, Joachim Spranger, Ilja Demuth, Elisabeth Steinhagen-Thiessen
  Diabetologie und Stoffwechsel.2020; 15(05): 400.     CrossRef
• Effect of Dietary Silk Peptide on Obesity, Hyperglycemia, and Skeletal Muscle Regeneration in High-Fat Diet-Fed Mice
  Kippeum Lee, Heegu Jin, Sungwoo Chei, Hyun-Ji Oh, Jeong-Yong Lee, Boo-Yong Lee
  Cells.2020; 9(2): 377.     CrossRef
• Nutrition Management in Older Adults with Diabetes: A Review on the Importance of Shifting Prevention Strategies from Metabolic Syndrome to Frailty
  Yoshiaki Tamura, Takuya Omura, Kenji Toyoshima, Atsushi Araki
  Nutrients.2020; 12(11): 3367.     CrossRef
• Mechanical Properties of Single Muscle Fibers: Understanding Poor Muscle Quality in Older Adults with Diabetes
  Eun-Jeong Lee, Hak Chul Jang, Kyung-Hoi Koo, Hye-Young Kim, Jae-Young Lim
  Annals of Geriatric Medicine and Research.2020; 24(4): 267.     CrossRef
• Mortality is not increased with Diabetes in hospitalised very old adults: a multi-site review
  Peter Smerdely
  BMC Geriatrics.2020;[Epub]     CrossRef
• Falls and Fractures in Diabetes—More than Bone Fragility
  Nicklas Højgaard Rasmussen, Jakob Dal
  Current Osteoporosis Reports.2019; 17(3): 147.     CrossRef
• Measuring gait speed to better identify prodromal dementia
  Giulia Grande, Federico Triolo, Arturo Nuara, Anna-Karin Welmer, Laura Fratiglioni, Davide L. Vetrano
  Experimental Gerontology.2019; 124: 110625.     CrossRef
• Diabetes and Muscle Dysfunction in Older Adults
  Hak Chul Jang
  Annals of Geriatric Medicine and Research.2019; 23(4): 160.     CrossRef
• Association between sarcopenia and diabetes in community dwelling elderly in the Amazon region – Viver Mais Project
  Anelza Biene Farias Souza, David Anchieta Costa Nascimento, Isabella Juliana Manfredo Rodrigues, Cynthia Cillene Oliveira Charone, Geovanna Lemos Lopes, Rondinei Silva Lima, Ana Amália Sá, Thiago Xavier Carneiro, Niele Silva Moraes
  Archives of Gerontology and Geriatrics.2019; 83: 121.     CrossRef
• Association between deterioration in muscle strength and peripheral neuropathy in people with diabetes
  Tae Jung Oh, Sunyoung Kang, Jie-Eun Lee, Jae Hoon Moon, Sung Hee Choi, Soo Lim, Hak Chul Jang
  Journal of Diabetes and its Complications.2019; 33(8): 598.     CrossRef
• Frailty and Disability in Diabetes
  Sol-Ji Yoon, Kwang-il Kim
  Annals of Geriatric Medicine and Research.2019; 23(4): 165.     CrossRef
• Mechanisms Involved in Glycemic Control Promoted by Exercise in Diabetics
  Eric Francelino Andrade, Víviam de Oliveira Silva, Débora Ribeiro Orlando, Luciano José Pereira
  Current Diabetes Reviews.2019; 15(2): 105.     CrossRef
• Response: The Differential Association between Muscle Strength and Diabetes Mellitus According to the Presence or Absence of Obesity (J Obes Metab Syndr 2019;28:46-52)
  Bo Kyung Koo
  Journal of Obesity & Metabolic Syndrome.2019; 28(4): 297.     CrossRef
• Diabetic Peripheral Neuropathy as a Risk Factor for Sarcopenia
  Tae Jung Oh, Yoojung Song, Jae Hoon Moon, Sung Hee Choi, Hak Chul Jang
  Annals of Geriatric Medicine and Research.2019; 23(4): 170.     CrossRef
• Sarcopenia and hospital-related outcomes in the old people: a systematic review and meta-analysis
  Yunli Zhao, Yunxia Zhang, Qiukui Hao, Meiling Ge, Birong Dong
  Aging Clinical and Experimental Research.2019; 31(1): 5.     CrossRef
• The Differential Association between Muscle Strength and Diabetes Mellitus According to the Presence or Absence of Obesity
  Bo Kyung Koo
  Journal of Obesity & Metabolic Syndrome.2019; 28(1): 46.     CrossRef
• Sarcopenia in elderly patients with type 2 diabetes mellitus: prevalence and related clinical factors
  Yuko Murata, Yoshiki Kadoya, Shoichi Yamada, Tokio Sanke
  Diabetology International.2018; 9(2): 136.     CrossRef
• Assessment of lower extremity muscle mass, muscle strength, and exercise therapy in elderly patients with diabetes mellitus
  Takuo Nomura, Toshihiro Kawae, Hiroaki Kataoka, Yukio Ikeda
  Environmental Health and Preventive Medicine.2018;[Epub]     CrossRef
• Diabetes Treatment in the Elderly: Incorporating Geriatrics, Technology, and Functional Medicine
  Willy Marcos Valencia, Diana Botros, Maria Vera-Nunez, Stuti Dang
  Current Diabetes Reports.2018;[Epub]     CrossRef
• Psoas and paraspinous muscle index as a predictor of mortality in African American men with type 2 diabetes mellitus
  Mariana Murea, Leon Lenchik, Thomas C. Register, Gregory B. Russell, Jianzhao Xu, S. Carrie Smith, Donald W. Bowden, Jasmin Divers, Barry I. Freedman
  Journal of Diabetes and its Complications.2018; 32(6): 558.     CrossRef
• Presence of Sarcopenia and Its Rate of Change Are Independently Associated with Long-term Mortality in Patients with Liver Cirrhosis
  Jae Yoon Jeong, Sanghyeok Lim, Joo Hyun Sohn, Jae Gon Lee, Dae Won Jun, Yongsoo Kim
  Journal of Korean Medical Science.2018;[Epub]     CrossRef
• Comparison between Dual-Energy X-ray Absorptiometry and Bioelectrical Impedance Analyses for Accuracy in Measuring Whole Body Muscle Mass and Appendicular Skeletal Muscle Mass
  Seo Young Lee, Soyeon Ahn, Young Ji Kim, Myoung Jin Ji, Kyoung Min Kim, Sung Hee Choi, Hak Chul Jang, Soo Lim
  Nutrients.2018; 10(6): 738.     CrossRef
• The association of low muscle mass with soluble receptor for advanced glycation end products (sRAGE): The Korean Sarcopenic Obesity Study (KSOS)
  Tae Nyun Kim, Man Sik Park, Eun Joo Lee, Hye Soo Chung, Hye Jin Yoo, Hyun Joo Kang, Wook Song, Sei Hyun Baik, Kyung Mook Choi
  Diabetes/Metabolism Research and Reviews.2018;[Epub]     CrossRef
• Obesity paradox on the survival of elderly patients with diabetes: an AHAP-based study
  Ali Bijani, Robert G. Cumming, Seyed-Reza Hosseini, Masoumeh Yazdanpour, Mahdis Rahimi, Abbas Sahebian, Reza Ghadimi
  Journal of Diabetes & Metabolic Disorders.2018; 17(1): 45.     CrossRef
• Effects of Seahorse Supplementation on Muscle Mass, Exercise Performance Abilities and the Related Blood Factors in Healthy Elderly Women
  Bae-jin LEE, Chan-ho PARK, Byeong-Hwan JEON
  JOURNAL OF FISHRIES AND MARINE SCIENCES EDUCATION.2018; 30(2): 409.     CrossRef
• Frailty risk in hospitalised older adults with and without diabetes mellitus
  Deborah A. Lekan, Thomas P. McCoy
  Journal of Clinical Nursing.2018; 27(19-20): 3510.     CrossRef
• Sarcopenia
  А.А. Пальцын
  ZHurnal «Patologicheskaia fiziologiia i eksperimental`naia terapiia».2018; (2()): 113.     CrossRef
• Prevention of Falls and Frailty in Older Adults with Diabetes
  Helen P. Hazuda, Sara E. Espinoza
  Current Geriatrics Reports.2017; 6(3): 158.     CrossRef
• Patterns and Predictors of Frailty Transitions in Older Men: The Osteoporotic Fractures in Men Study
  Lauren R. Pollack, Stephanie Litwack‐Harrison, Peggy M. Cawthon, Kristine Ensrud, Nancy E. Lane, Elizabeth Barrett‐Connor, Thuy‐Tien Dam
  Journal of the American Geriatrics Society.2017; 65(11): 2473.     CrossRef
• Diabetic Neuropathy and Gait: A Review
  Uazman Alam, David R. Riley, Ravinder S. Jugdey, Shazli Azmi, Satyan Rajbhandari, Kristiaan D’Août, Rayaz A. Malik
  Diabetes Therapy.2017; 8(6): 1253.     CrossRef
• Care of older people with diabetes
  Trisha Dunning
  Nursing Standard.2017; 32(3): 50.     CrossRef
• Decreased Muscle Strength and Quality in Diabetes-Related Dementia
  Akito Tsugawa, Yusuke Ogawa, Naoto Takenoshita, Yoshitsugu Kaneko, Hirokuni Hatanaka, Eriko Jaime, Raita Fukasawa, Haruo Hanyu
  Dementia and Geriatric Cognitive Disorders Extra.2017; 7(3): 454.     CrossRef
• Aging of the endocrine system and its potential impact on sarcopenia
  Giovanni Vitale, Matteo Cesari, Daniela Mari
  European Journal of Internal Medicine.2016; 35: 10.     CrossRef

Citations

Citations to this article as recorded by  

• Telehealth Technologies in Diabetes Self-management and Education
  Vidya Sharma, Marie Feldman, Ramaswamy Sharma
  Journal of Diabetes Science and Technology.2024; 18(1): 148.     CrossRef
• Analysis and mapping the research landscape on patient‐centred care in the context of chronic disease management
  Waleed M. Sweileh
  Journal of Evaluation in Clinical Practice.2024; 30(4): 638.     CrossRef
• App Design Features Important for Diabetes Self-management as Determined by the Self-Determination Theory on Motivation: Content Analysis of Survey Responses From Adults Requiring Insulin Therapy
  Helen N C Fu, Jean F Wyman, Cynthia J Peden-McAlpine, Claire Burke Draucker, Titus Schleyer, Terrence J Adam
  JMIR Diabetes.2023; 8: e38592.     CrossRef
• The Clinical Impact of Flash Glucose Monitoring—a Digital Health App and Smartwatch Technology in Patients With Type 2 Diabetes: Scoping Review
  Sergio Diez Alvarez, Antoni Fellas, Derek Santos, Dean Sculley, Katie Wynne, Shamasunder Acharya, Pooshan Navathe, Xavier Girones, Andrea Coda
  JMIR Diabetes.2023; 8: e42389.     CrossRef
• User Retention and Engagement in the Digital-Based Diabetes Education and Self-Management for Ongoing and Newly Diagnosed (myDESMOND) Program: Descriptive Longitudinal Study
  Mary M Barker, Radhika Chauhan, Melanie J Davies, Christopher Brough, Alison Northern, Bernie Stribling, Sally Schreder, Kamlesh Khunti, Michelle Hadjiconstantinou
  JMIR Diabetes.2023; 8: e44943.     CrossRef
• New Digital Health Technologies for Insulin Initiation and Optimization for People With Type 2 Diabetes
  David Kerr, Steven Edelman, Giacomo Vespasiani, Kamlesh Khunti
  Endocrine Practice.2022; 28(8): 811.     CrossRef
• Effects of Patient-Driven Lifestyle Modification Using Intermittently Scanned Continuous Glucose Monitoring in Patients With Type 2 Diabetes: Results From the Randomized Open-label PDF Study
  Hun Jee Choe, Eun-Jung Rhee, Jong Chul Won, Kyong Soo Park, Won-Young Lee, Young Min Cho
  Diabetes Care.2022; 45(10): 2224.     CrossRef
• Assessing the Acceptability and Effectiveness of Mobile-Based Physical Activity Interventions for Midlife Women During Menopause: Systematic Review of the Literature
  Ghada AlSwayied, Haoyue Guo, Tasmin Rookes, Rachael Frost, Fiona L Hamilton
  JMIR mHealth and uHealth.2022; 10(12): e40271.     CrossRef
• Application of the National Institute for Health and Care Excellence Evidence Standards Framework for Digital Health Technologies in Assessing Mobile-Delivered Technologies for the Self-Management of Type 2 Diabetes Mellitus: Scoping Review
  Jessica R Forsyth, Hannah Chase, Nia W Roberts, Laura C Armitage, Andrew J Farmer
  JMIR Diabetes.2021; 6(1): e23687.     CrossRef
• Mobile Healthcare System Provided by Primary Care Physicians Improves Quality of Diabetes Care
  Tae Jung Oh, Jie-Eun Lee, Seok Kim, Sooyoung Yoo, Hak Chul Jang
  CardioMetabolic Syndrome Journal.2021; 1(1): 88.     CrossRef
• Self-Care IoT Platform for Diabetic Mellitus
  Jai-Chang Park, Seongbeom Kim, Je-Hoon Lee
  Applied Sciences.2021; 11(5): 2006.     CrossRef
• Diabetes clinic reinvented: will technology change the future of diabetes care?
  Marwa Al-Badri, Osama Hamdy
  Therapeutic Advances in Endocrinology and Metabolism.2021; 12: 204201882199536.     CrossRef
• Analysis of Effectiveness and Psychological Techniques Implemented in mHealth Solutions for Middle-Aged and Elderly Adults with Type 2 Diabetes: A Narrative Review of the Literature
  Julia Vázquez-de Sebastián, Andreea Ciudin, Carmina Castellano-Tejedor
  Journal of Clinical Medicine.2021; 10(12): 2701.     CrossRef
• Therapeutic Exercise Platform for Type-2 Diabetic Mellitus
  Je-Hoon Lee, Jai-Chang Park, Seong-Beom Kim
  Electronics.2021; 10(15): 1820.     CrossRef
• Accuracy comparison study of new smartphone-based semen analyzer versus laboratory sperm quality analyzer
  Min Jung Park, Mi Young Lim, Hyun Jun Park, Nam Cheol Park
  Investigative and Clinical Urology.2021; 62(6): 672.     CrossRef
• User Retention and Engagement With a Mobile App Intervention to Support Self-Management in Australians With Type 1 or Type 2 Diabetes (My Care Hub): Mixed Methods Study
  Mary D Adu, Usman H Malabu, Aduli EO Malau-Aduli, Aaron Drovandi, Bunmi S Malau-Aduli
  JMIR mHealth and uHealth.2020; 8(6): e17802.     CrossRef
• The role of telehealth counselling with mobile self-monitoring on blood pressure reduction among overseas Koreans with high blood pressure in Vietnam
  Hyang Yuol Lee, Ju Young Kim, Ki Young Na, Hwa Yeon Park, Jinah Han, Yuliya Pak, Bola Nam, Chae Hyun Pae, Jisun Lee, Tae Ho Lim, Donghun Lee
  Journal of Telemedicine and Telecare.2019; 25(4): 241.     CrossRef
• The Effect of a Smartphone-Based, Patient-Centered Diabetes Care System in Patients With Type 2 Diabetes: A Randomized, Controlled Trial for 24 Weeks
  Eun Ky Kim, Soo Heon Kwak, Hye Seung Jung, Bo Kyung Koo, Min Kyong Moon, Soo Lim, Hak Chul Jang, Kyong Soo Park, Young Min Cho
  Diabetes Care.2019; 42(1): 3.     CrossRef
• Patient-Driven Diabetes Care of the Future in the Technology Era
  Sahar Ashrafzadeh, Osama Hamdy
  Cell Metabolism.2019; 29(3): 564.     CrossRef
• Peripartum Management of Gestational Diabetes Using a Digital Health Care Service: A Pilot, Randomized Controlled Study
  Ji-Hee Sung, Da Young Lee, Kyoung Pil Min, Cheol-Young Park
  Clinical Therapeutics.2019; 41(11): 2426.     CrossRef
• The Effects of Dietary Mobile Apps on Nutritional Outcomes in Adults with Chronic Diseases: A Systematic Review and Meta-Analysis
  Cosette Fakih El Khoury, Mirey Karavetian, Ruud J.G. Halfens, Rik Crutzen, Lama Khoja, Jos M.G.A. Schols
  Journal of the Academy of Nutrition and Dietetics.2019; 119(4): 626.     CrossRef
• Diabetes Mellitus m-Health Applications: A Systematic Review of Features and Fundamentals
  Ericles Andrei Bellei, Daiana Biduski, Nathália Pinto Cechetti, Ana Carolina Bertoletti De Marchi
  Telemedicine and e-Health.2018; 24(11): 839.     CrossRef
• Multifunctional Wearable System that Integrates Sweat‐Based Sensing and Vital‐Sign Monitoring to Estimate Pre‐/Post‐Exercise Glucose Levels
  Yongseok Joseph Hong, Hyunjae Lee, Jaemin Kim, Minha Lee, Hyung Jin Choi, Taeghwan Hyeon, Dae‐Hyeong Kim
  Advanced Functional Materials.2018;[Epub]     CrossRef
• Smart Devices for Older Adults Managing Chronic Disease: A Scoping Review
  Ben YB Kim, Joon Lee
  JMIR mHealth and uHealth.2017; 5(5): e69.     CrossRef
• Usability and clinical efficacy of diabetes mobile applications for adults with type 2 diabetes: A systematic review
  Helen Fu, Siobhan K. McMahon, Cynthia R. Gross, Terrence J. Adam, Jean F. Wyman
  Diabetes Research and Clinical Practice.2017; 131: 70.     CrossRef
• Novel device for male infertility screening with single-ball lens microscope and smartphone
  Yoshitomo Kobori, Peter Pfanner, Gail S. Prins, Craig Niederberger
  Fertility and Sterility.2016; 106(3): 574.     CrossRef

Citations

Citations to this article as recorded by  

• Impaired Awareness of Hypoglycemia and its Risk Factors among Diabetic Patients in Jazan, Saudi Arabia: A Cross-Sectional Study
  Omar Oraibi, Abdulelah Alameer, Mohammed Dalak, Sawsan Alsharif, Shatha A. Hakami, Mohammed Sumayli, Ayman Shami, Mostafa Mohrag, Mohammed A. Madkhali, Mohammed Ali Madkhali, Luai Alhazmi, Majid Darraj
  Current Diabetes Reviews.2024;[Epub]     CrossRef
• The prognostic value of the stress hyperglycemia ratio for all-cause and cardiovascular mortality in patients with diabetes or prediabetes: insights from NHANES 2005–2018
  Lei Ding, Hongda Zhang, Cong Dai, Aikai Zhang, Fengyuan Yu, Lijie Mi, Yingjie Qi, Min Tang
  Cardiovascular Diabetology.2024;[Epub]     CrossRef
• Navigating the future of diabetes: innovative nomogram models for predicting all-cause mortality risk in diabetic nephropathy
  Sensen Wu, Hui Wang, Dikang Pan, Julong Guo, Fan Zhang, Yachan Ning, Yongquan Gu, Lianrui Guo
  BMC Nephrology.2024;[Epub]     CrossRef
• Association of hypoglycaemia with the risks of arrhythmia and mortality in individuals with diabetes - a systematic review and meta-analysis
  Gangfeng Li, Shuping Zhong, Xingmu Wang, Fuyuan Zhuge
  Frontiers in Endocrinology.2023;[Epub]     CrossRef
• Diabetes mellitus und Straßenverkehr – ein Positionspapier der Österreichischen Diabetesgesellschaft (Update 2023)
  Heidemarie Abrahamian, Birgit Salamon, Angelika Lahnsteiner, Christian Schelkshorn, Alexander Bräuer, Lars Stechemesser, Gerd Köhler, Martin Clodi
  Wiener klinische Wochenschrift.2023; 135(S1): 319.     CrossRef
• Validation of the hypoglycemia awareness questionnaire to assess hypoglycemia awareness in patients with type 2 diabetes treated with insulin
  Diana Cristina Henao-Carrillo, Fabio Alexander Sierra-Matamoros, Ana Julia Carrillo Algarra, Julieth Patricia García-Lugo, Sandra Milena Hernández-Zambrano
  Diabetes & Metabolic Syndrome: Clinical Research & Reviews.2023; 17(12): 102917.     CrossRef
• Basal insulin analogues in people with diabetes and chronic kidney disease
  David León‐Jiménez, José Pablo Miramontes‐González, Laura Márquez‐López, Francisco Astudillo‐Martín, Luis M. Beltrán‐Romero, Fernando Moreno‐Obregón, Javier Escalada‐San Martín
  Diabetic Medicine.2022;[Epub]     CrossRef
• Severe Hypoglycemia Increases Dementia Risk and Related Mortality: A Nationwide, Population-based Cohort Study
  Eugene Han, Kyung-do Han, Byung-Wan Lee, Eun Seok Kang, Bong-Soo Cha, Seung-Hyun Ko, Yong-ho Lee
  The Journal of Clinical Endocrinology & Metabolism.2022; 107(5): e1976.     CrossRef
• Validación transcultural del HypoA-Q para medir conciencia de hipoglucemia en pacientes diabéticos
  Ana Julia Carrillo-Algarra, Sandra Milena Hernandez-Zambrano, Fabio Alexander Sierra-Matamoros, Diana Cristina Henao-Carrillo, Ana María Gómez-Medina, Daniel Esteban Hurtado-Barrera
  Revista Ciencia y Cuidado.2022; 19(1): 42.     CrossRef
• Validity of the diagnosis of diabetic microvascular complications in Korean national health insurance claim data
  Hyung Jun Kim, Moo-Seok Park, Jee-Eun Kim, Tae-Jin Song
  Annals of Clinical Neurophysiology.2022; 24(1): 7.     CrossRef
• Severe hypoglycemia as a risk factor for cardiovascular outcomes in patients with type 2 diabetes: is it preventable?
  Seung-Hyun Ko
  Cardiovascular Prevention and Pharmacotherapy.2022; 4(3): 106.     CrossRef
• Evaluation of a Clinical Platform to Promote Chronic Disease Management
  Laura Greene, Nila Sathe, John A. House, Laura L. Schott, Stella Safo
  Population Health Management.2021; 24(4): 470.     CrossRef
• Severe hypoglycemia as a preventable risk factor for cardiovascular disease in patients with type 2 diabetes mellitus
  Soo-Yeon Choi, Seung-Hyun Ko
  The Korean Journal of Internal Medicine.2021; 36(2): 263.     CrossRef
• Meta-Analysis: Association Between Hypoglycemia and Serious Adverse Events in Older Patients Treated With Glucose-Lowering Agents
  Katharina Mattishent, Yoon K. Loke
  Frontiers in Endocrinology.2021;[Epub]     CrossRef
• Epidemiology and outcomes from severe hypoglycemia in Kuwait: a prospective cohort study
  Dalal Al Hasan, Ameen Yaseen, Mohammad Al Roudan, Lee Wallis
  BMC Emergency Medicine.2021;[Epub]     CrossRef
• The incidence of hypoglycemia and its risk factors among diabetic patients in the Eastern Province of Saudi Arabia
  Ahmed Elshebiny, Hassan Alali, Zainab Alamer, Yasmin Alsultan, Hashim Alkhalaf, Abdullah Alkishi, Mohammed Alsuwaylih
  International Journal of Medicine in Developing Countries.2021; : 614.     CrossRef
• Current trends in epidemiology of cardiovascular disease and cardiovascular risk management in type 2 diabetes
  Jae-Seung Yun, Seung-Hyun Ko
  Metabolism.2021; 123: 154838.     CrossRef
• Real-world Evaluation of glycemic control and hypoglycemic Events among type 2 Diabetes mellitus study (REEDS): a multicentre, cross-sectional study in Thailand
  Bancha Satirapoj, Thongchai Pratipanawatr, Boonsong Ongphiphadhanakul, Sompongse Suwanwalaikorn, Yupin Benjasuratwong, Wannee Nitiyanant
  BMJ Open.2020; 10(2): e031612.     CrossRef

• Predictors of Diabetes Self-Care Practice Among Patients with Type 2 Diabetes in Public Hospitals in Northeastern Ethiopia: A Facility-Based Cross-Sectional Study

  
  Tesfaye Molla Gulentie, Ebrahim Mohammed Yesuf, Taklo Simeneh Yazie, Belayneh Kefale
  Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy.2020; Volume 13: 3137.     CrossRef
• Hypoglycemia in Older Patients
  Byron J. Hoogwerf
  Clinics in Geriatric Medicine.2020; 36(3): 395.     CrossRef
• Severe hypoglycaemia and absolute risk of cause-specific mortality in individuals with type 2 diabetes: a UK primary care observational study
  Francesco Zaccardi, Suping Ling, Claire Lawson, Melanie J. Davies, Kamlesh Khunti
  Diabetologia.2020; 63(10): 2129.     CrossRef
• Insulin Glargine U100 Improved Glycemic Control and Reduced Nocturnal Hypoglycemia in Patients with Type 2 Diabetes Mellitus and Chronic Kidney Disease Stages 3 and 4
  Carolina C. Betônico, Silvia Maria O. Titan, Aécio Lira, Tatiana S. Pelaes, Maria Lúcia C. Correa-Giannella, Márcia Nery, Márcia Queiroz
  Clinical Therapeutics.2019; 41(10): 2008.     CrossRef
• Efficacy and Safety of Degludec Compared to Glargine 300 Units/mL in Insulin-Experienced Patients With Type 2 Diabetes: Trial Protocol Amendment (NCT03078478)
  Athena Philis-Tsimikas, Irene Stratton, Lone Nørgård Troelsen, Britta Anker Bak, Lawrence A. Leiter
  Journal of Diabetes Science and Technology.2019; 13(3): 498.     CrossRef
• Efficacy and safety of insulin glargine/lixisenatide (iGlarLixi) fixed-ratio combination in older adults with type 2 diabetes
  Yehuda Handelsman, Christina Chovanes, Terry Dex, Francesco Giorgino, Neil Skolnik, Elisabeth Souhami, William Stager, Elisabeth Niemoeller, Juan Pablo Frias
  Journal of Diabetes and its Complications.2019; 33(3): 236.     CrossRef
• Urinary glucose excretion after dapagliflozin treatment: An exposure‐response modelling comparison between Japanese and non‐Japanese patients diagnosed with type 1 diabetes mellitus
  Victor Sokolov, Tatiana Yakovleva, Shinya Ueda, Joanna Parkinson, David W. Boulton, Robert C. Penland, Weifeng Tang
  Diabetes, Obesity and Metabolism.2019; 21(4): 829.     CrossRef
• Effects on clinical outcomes of intensifying triple oral antidiabetic drug (OAD) therapy by initiating insulin versus enhancing OAD therapy in patients with type 2 diabetes: A nationwide population‐based, propensity‐score‐matched cohort study
  Shihchen Kuo, Chun‐Ting Yang, Jin‐Shang Wu, Huang‐Tz Ou
  Diabetes, Obesity and Metabolism.2019; 21(2): 312.     CrossRef
• Cardiovascular safety and lower severe hypoglycaemia of insulin degludec versus insulin glargine U100 in patients with type 2 diabetes aged 65 years or older: Results from DEVOTE (DEVOTE 7)
  Richard E. Pratley, Scott S. Emerson, Edward Franek, Matthew P. Gilbert, Steven P. Marso, Darren K. McGuire, Thomas R. Pieber, Bernard Zinman, Charlotte T. Hansen, Melissa V. Hansen, Thomas Mark, Alan C. Moses, John B. Buse
  Diabetes, Obesity and Metabolism.2019; 21(7): 1625.     CrossRef
• Review of the cardiovascular safety of dipeptidyl peptidase-4 inhibitors and the clinical relevance of the CAROLINA trial
  Marile Santamarina, Curt J. Carlson
  BMC Cardiovascular Disorders.2019;[Epub]     CrossRef
• Effects of a 12-week moderate-intensity exercise training on blood glucose response in patients with type 2 diabetes
  Shang-Lin Chiang, Margaret McLean Heitkemper, Yi-Jen Hung, Wen-Chii Tzeng, Meei-Shyuan Lee, Chia-Huei Lin
  Medicine.2019; 98(36): e16860.     CrossRef
• Impaired Awareness of Hypoglycaemia in Insulin-treated Type 2 Diabetes Mellitus
  Mohammad J. Alkhatatbeh, Nedaa A. Abdalqader , Mohammad A.Y. Alqudah
  Current Diabetes Reviews.2019; 15(5): 407.     CrossRef
• Hypoglycaemia, cardiovascular disease, and mortality in diabetes: epidemiology, pathogenesis, and management
  Stephanie A Amiel, Pablo Aschner, Belinda Childs, Philip E Cryer, Bastiaan E de Galan, Brian M Frier, Linda Gonder-Frederick, Simon R Heller, Timothy Jones, Kamlesh Khunti, Lawrence A Leiter, Yingying Luo, Rory J McCrimmon, Ulrik Pedersen-Bjergaard, Eliza
  The Lancet Diabetes & Endocrinology.2019; 7(5): 385.     CrossRef
• Sulfonylureas as initial treatment for type 2 diabetes and the risk of adverse cardiovascular events: A population‐based cohort study
  Kristian B. Filion, Antonios Douros, Laurent Azoulay, Hui Yin, Oriana H. Yu, Samy Suissa
  British Journal of Clinical Pharmacology.2019; 85(10): 2378.     CrossRef
• Selectivity of beta-blockers, cardiovascular and all-cause mortality in people with hypoglycaemia: An observational study
  F. Zaccardi, L.L. Nystrup Husemoen, B.L. Thorsted, D.R. Webb, S.K. Paul, M.J. Davies, K. Khunti
  Nutrition, Metabolism and Cardiovascular Diseases.2019; 29(5): 481.     CrossRef
• Cost-effectiveness of a primary care multidisciplinary Risk Assessment and Management Program for patients with diabetes mellitus (RAMP-DM) over lifetime
  Fangfang Jiao, Eric Yuk Fai Wan, Colman Siu Cheung Fung, Anca Ka Chun Chan, Sarah Morag McGhee, Ruby Lai Ping Kwok, Cindy Lo Kuen Lam
  Endocrine.2019; 63(2): 259.     CrossRef
• Efficacy and safety of sensor-augmented pump therapy (SAPT) with predictive low-glucose management in patients diagnosed with type 1 diabetes mellitus previously treated with SAPT and low glucose suspend
  Ana María Gómez, Diana Cristina Henao, Angelica Imitola, Oscar Mauricio Muñoz, Martín Alonso Rondón Sepúlveda, Laura Kattah, Juan Sebastian Guerrero, Elly Morros, Juan Pablo Llano, Maira García Jaramillo, Fabián León-Vargas
  Endocrinología, Diabetes y Nutrición.2018; 65(8): 451.     CrossRef
• Recent diabetes-related mortality trends in Romania
  Sorin Ioacara, Elisabeta Sava, Olivia Georgescu, Anca Sirbu, Simona Fica
  Acta Diabetologica.2018; 55(8): 821.     CrossRef
• Use of sodium-glucose co-transporter-2 inhibitors from clinical trial results to practical application in Russia
  D. A. Lebedev, A. Yu. Babenko
  Medical Council.2018; (16): 100.     CrossRef
• Severe hypoglycemia is a risk factor for atrial fibrillation in type 2 diabetes mellitus: Nationwide population-based cohort study
  Seung-Hyun Ko, Yong-Moon Park, Jae-Seung Yun, Seon-Ah Cha, Eue-Keun Choi, Kyungdo Han, Eugene Han, Yong-ho Lee, Yu-Bae Ahn
  Journal of Diabetes and its Complications.2018; 32(2): 157.     CrossRef
• Antioxidant effects of epigallocatechin-3-gallate on the aTC1-6 pancreatic alpha cell line
  Ting Cao, Xiong Zhang, Dan Yang, Yue-Qian Wang, Zheng-Dong Qiao, Jian-Ming Huang, Peng Zhang
  Biochemical and Biophysical Research Communications.2018; 495(1): 693.     CrossRef
• Hemoglobin glycation index predicts cardiovascular disease in people with type 2 diabetes mellitus: A 10-year longitudinal cohort study
  Mee Kyoung Kim, Jee Sun Jeong, Jae-Seung Yun, Hyuk-Sang Kwon, Ki Hyun Baek, Ki-Ho Song, Yu-Bae Ahn, Seung-Hyun Ko
  Journal of Diabetes and its Complications.2018; 32(10): 906.     CrossRef
• Day-to-day fasting glycaemic variability in DEVOTE: associations with severe hypoglycaemia and cardiovascular outcomes (DEVOTE 2)
  Bernard Zinman, Steven P. Marso, Neil R. Poulter, Scott S. Emerson, Thomas R. Pieber, Richard E. Pratley, Martin Lange, Kirstine Brown-Frandsen, Alan Moses, Ann Marie Ocampo Francisco, Jesper Barner Lekdorf, Kajsa Kvist, John B. Buse
  Diabetologia.2018; 61(1): 48.     CrossRef
• Efficacy and safety of sensor-augmented pump therapy (SAPT) with predictive low-glucose management in patients diagnosed with type 1 diabetes mellitus previously treated with SAPT and low glucose suspend
  Ana María Gómez, Diana Cristina Henao, Angelica Imitola, Oscar Mauricio Muñoz, Martín Alonso Rondón Sepúlveda, Laura Kattah, Juan Sebastian Guerrero, Elly Morros, Juan Pablo Llano, Maira García Jaramillo, Fabián León-Vargas
  Endocrinología, Diabetes y Nutrición (English ed.).2018; 65(8): 451.     CrossRef
• Time- and frequency-domain measures of heart rate variability predict cardiovascular outcome in patients with type 2 diabetes
  Seon-Ah Cha, Yong-Moon Park, Jae-Seung Yun, Seung-Hwan Lee, Yu-Bae Ahn, Sung-Rae Kim, Seung-Hyun Ko
  Diabetes Research and Clinical Practice.2018; 143: 159.     CrossRef
• Newly diagnosed type 2 diabetes in an ethnic minority population: clinical presentation and comparison to other populations
  Michael Morkos, Bettina Tahsin, Louis Fogg, Leon Fogelfeld
  BMJ Open Diabetes Research & Care.2018; 6(1): e000568.     CrossRef
• DEVOTE 3: temporal relationships between severe hypoglycaemia, cardiovascular outcomes and mortality
  Thomas R. Pieber, Steven P. Marso, Darren K. McGuire, Bernard Zinman, Neil R. Poulter, Scott S. Emerson, Richard E. Pratley, Vincent Woo, Simon Heller, Martin Lange, Kirstine Brown-Frandsen, Alan Moses, Jesper Barner Lekdorf, Lucine Lehmann, Kajsa Kvist,
  Diabetologia.2018; 61(1): 58.     CrossRef
• Intervention effects of Compound Houttuyniae Herba to diabetic renal damage based on SOCS-JAK/STAT negative feedback regulation
  Yun Fang, Sai-cong Shao, Hai-ying Wang
  Chinese Herbal Medicines.2018; 10(4): 424.     CrossRef
• Monotherapy in Patients with Type 2 Diabetes Mellitus
  Sang Youl Rhee, Hyun Jin Kim, Seung-Hyun Ko, Kyu-Yeon Hur, Nan-Hee Kim, Min Kyong Moon, Seok-O Park, Byung-Wan Lee, Kyung Mook Choi, Jin Hwa Kim
  Diabetes & Metabolism Journal.2017; 41(5): 349.     CrossRef
• Monotherapy in patients with type 2 diabetes mellitus
  Sang Youl Rhee, Hyun Jin Kim, Seung-Hyun Ko, Kyu Yeon Hur, Nan-Hee Kim, Min Kyong Moon, Seok-O Park, Byung-Wan Lee, Kyung Mook Choi, Jin Hwa Kim
  The Korean Journal of Internal Medicine.2017; 32(6): 959.     CrossRef
• Antihyperglycemic agent therapy for adult patients with type 2 diabetes mellitus 2017: a position statement of the Korean Diabetes Association
  Seung-Hyun Ko, Kyu-Yeon Hur, Sang Youl Rhee, Nan-Hee Kim, Min Kyong Moon, Seok-O Park, Byung-Wan Lee, Hyun Jin Kim, Kyung Mook Choi, Jin Hwa Kim
  The Korean Journal of Internal Medicine.2017; 32(6): 947.     CrossRef
• Cardiovascular effects of dipeptidyl peptidase-4 inhibitor in diabetic patients with and without established cardiovascular disease: a meta-analysis and systematic review
  Shishi Xu, Xinyue Zhang, Lizhi Tang, Fang Zhang, Nanwei Tong
  Postgraduate Medicine.2017; 129(2): 205.     CrossRef
• Antihyperglycemic Agent Therapy for Adult Patients with Type 2 Diabetes Mellitus 2017: A Position Statement of the Korean Diabetes Association
  Seung-Hyun Ko, Kyu-Yeon Hur, Sang Youl Rhee, Nan-Hee Kim, Min Kyong Moon, Seok-O Park, Byung-Wan Lee, Hyun Jin Kim, Kyung Mook Choi, Jin Hwa Kim
  Diabetes & Metabolism Journal.2017; 41(5): 337.     CrossRef
• Effects of propofol on myocardial ischemia-reperfusion injury in rats with type-2 diabetes mellitus
  Ying Wang, Xiuru Qi, Chunliang Wang, Danning Zhao, Hongjie Wang, Jianxin Zhang
  Biomedical Reports.2017; 6(1): 69.     CrossRef
• Cardiovascular risk assessment in patients with diabetes
  Marcello Casaccia Bertoluci, Viviane Zorzanelli Rocha
  Diabetology & Metabolic Syndrome.2017;[Epub]     CrossRef
• Pathogenetic features of the combined course of arterial hypertension and diabetes mellitus 2 type
  O.M. Bilovol, L.R. Bobronnikova, O.V. Al-Trawneh
  Shidnoevropejskij zurnal vnutrisnoi ta simejnoi medicini.2017; 2017(1): 4.     CrossRef
• Risk Factors and Adverse Outcomes of Severe Hypoglycemia in Type 2 Diabetes Mellitus
  Jae-Seung Yun, Seung-Hyun Ko
  Diabetes & Metabolism Journal.2016; 40(6): 423.     CrossRef
• Real-world evidence for the safety of ipragliflozin in elderly Japanese patients with type 2 diabetes mellitus (STELLA-ELDER): final results of a post-marketing surveillance study
  Koutaro Yokote, Yasuo Terauchi, Ichiro Nakamura, Haruko Sugamori
  Expert Opinion on Pharmacotherapy.2016; 17(15): 1995.     CrossRef
• Hypoglycemia: Culprit or Bystander?
  You-Cheol Hwang
  Diabetes & Metabolism Journal.2016; 40(3): 190.     CrossRef
• Schwere Hypoglykämien erhöhen die Mortalität
  E. Fritschka
  MMW - Fortschritte der Medizin.2016; 158(S3): 46.     CrossRef

Citations

Citations to this article as recorded by  

• Diabetic fibrosis
  Izabela Tuleta, Nikolaos G. Frangogiannis
  Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease.2021; 1867(4): 166044.     CrossRef
• Protective roles of thymoquinone and vildagliptin in manganese-induced nephrotoxicity in adult albino rats
  Heba El-Sayed Mostafa, Eman Ahmed Alaa El-Din, Dalia Abdallah El-Shafei, Nehal S. Abouhashem, Aisha Abdallah Abouhashem
  Environmental Science and Pollution Research.2021; 28(24): 31174.     CrossRef
• Evogliptin, a Dipeptidyl Peptidase-4 Inhibitor, Attenuates Renal Fibrosis Caused by Unilateral Ureteral Obstruction in Mice
  Mi-Jin Kim, Na-young Kim, Yun-A Jung, Seunghyeong Lee, Gwon-Soo Jung, Jung-Guk Kim, In-Kyu Lee, Sungwoo Lee, Yeon-Kyung Choi, Keun-Gyu Park
  Diabetes & Metabolism Journal.2020; 44(1): 186.     CrossRef
• Gemigliptin Attenuates Renal Fibrosis Through Down-Regulation of the NLRP3 Inflammasome
  Jung Beom Seo, Yeon-Kyung Choi, Hye-In Woo, Yun-A Jung, Sungwoo Lee, Seunghyeong Lee, Mihyang Park, In-Kyu Lee, Gwon-Soo Jung, Keun-Gyu Park
  Diabetes & Metabolism Journal.2019; 43(6): 830.     CrossRef
• Recent advances in the pathogenesis of microvascular complications in diabetes
  Sungmi Park, Hyeon-Ji Kang, Jae-Han Jeon, Min-Ji Kim, In-Kyu Lee
  Archives of Pharmacal Research.2019; 42(3): 252.     CrossRef
• Diabetic nephropathy: An update on pathogenesis and drug development
  Vikram Rao A/L B Vasanth Rao, Sean Hong Tan, Mayuren Candasamy, Subrat Kumar Bhattamisra
  Diabetes & Metabolic Syndrome: Clinical Research & Reviews.2019; 13(1): 754.     CrossRef
• Mechanisms and pathways of anti‐inflammatory activity of DPP‐4 inhibitors in cardiovascular and renal protection
  Katarina Tomovic, Jelena Lazarevic, Gordana Kocic, Marina Deljanin‐Ilic, Marko Anderluh, Andrija Smelcerovic
  Medicinal Research Reviews.2019; 39(1): 404.     CrossRef
• Effects of Dipeptidyl Peptidase-4 Inhibitors on Renal Outcomes in Patients with Type 2 Diabetes: A Systematic Review and Meta-Analysis
  Jae Hyun Bae, Sunhee Kim, Eun-Gee Park, Sin Gon Kim, Seokyung Hahn, Nam Hoon Kim
  Endocrinology and Metabolism.2019; 34(1): 80.     CrossRef
• The emerging role of novel antihyperglycemic agents in the treatment of heart failure and diabetes: A focus on cardiorenal outcomes
  Kelly R. McHugh, Adam D. DeVore, Robert J. Mentz, Daniel Edmonston, Jennifer B. Green, Adrian F. Hernandez
  Clinical Cardiology.2018; 41(9): 1259.     CrossRef
• Acute Kidney Injury and Progression of Diabetic Kidney Disease
  Samuel Mon-Wei Yu, Joseph V. Bonventre
  Advances in Chronic Kidney Disease.2018; 25(2): 166.     CrossRef
• Recombinant human GLP-1(rhGLP-1) alleviating renal tubulointestitial injury in diabetic STZ-induced rats
  Weiqin Yin, Shiqing Xu, Zai Wang, Honglin Liu, Liang Peng, Qing Fang, Tingting Deng, Wenjian Zhang, Jinning Lou
  Biochemical and Biophysical Research Communications.2018; 495(1): 793.     CrossRef
• Chronic inhalation of e-cigarette vapor containing nicotine disrupts airway barrier function and induces systemic inflammation and multiorgan fibrosis in mice
  Laura E. Crotty Alexander, Christopher A. Drummond, Mark Hepokoski, Denzil Mathew, Alex Moshensky, Andrew Willeford, Soumita Das, Prabhleen Singh, Zach Yong, Jasmine H. Lee, Kevin Vega, Ashley Du, John Shin, Christian Javier, Jiang Tian, Joan Heller Brown
  American Journal of Physiology-Regulatory, Integrative and Comparative Physiology.2018; 314(6): R834.     CrossRef
• Renoprotective effect of fucoidan from Acaudina molpadioides in streptozotocin/high fat diet-induced type 2 diabetic mice
  Shiwei Hu, Jinhui Wang, Jingfeng Wang, Shijie Li, Wei Jiang, Yu Liu
  Journal of Functional Foods.2017; 31: 123.     CrossRef
• Dipeptidyl peptidase-4 inhibition and renoprotection
  Yuta Takagaki, Daisuke Koya, Keizo Kanasaki
  Current Opinion in Nephrology and Hypertension.2017; 26(1): 56.     CrossRef
• Treatment of diabetic kidney disease: current and future targets
  Mi-Kyung Kim
  The Korean Journal of Internal Medicine.2017; 32(4): 622.     CrossRef
• Pharmacological Treatment in Diabetes Mellitus Type 1 – Insulin and What Else?
  Ewa Otto-Buczkowska, Natalia Jainta
  International Journal of Endocrinology and Metabolism.2017;[Epub]     CrossRef
• GLP-1 and the kidney: from physiology to pharmacology and outcomes in diabetes
  Marcel H. A. Muskiet, Lennart Tonneijck, Mark M. Smits, Michaël J.B. van Baar, Mark H. H. Kramer, Ewout J. Hoorn, Jaap A. Joles, Daniël H. van Raalte
  Nature Reviews Nephrology.2017; 13(10): 605.     CrossRef
• Efficacy, safety and albuminuria‐reducing effect of gemigliptin in Korean type 2 diabetes patients with moderate to severe renal impairment: A 12‐week, double‐blind randomized study (the GUARD Study)
  Sun A. Yoon, Byoung G. Han, Sung G. Kim, Sang Y. Han, Young I. Jo, Kyung H. Jeong, Kook H. Oh, Hyeong C. Park, Sun H. Park, Shin W. Kang, Ki R. Na, Sun W. Kang, Nam H. Kim, Young H. Jang, Seong H. Shin, Dae R. Cha
  Diabetes, Obesity and Metabolism.2017; 19(4): 590.     CrossRef
• Sodium butyrate has context-dependent actions on dipeptidyl peptidase-4 and other metabolic parameters
  Eun-Sol Lee, Dong-Sung Lee, Prakash Raj Pandeya, Youn-Chul Kim, Dae-Gil Kang, Ho-Sub Lee, Byung-Chul Oh, Dae Ho Lee
  The Korean Journal of Physiology & Pharmacology.2017; 21(5): 519.     CrossRef
• Lobeglitazone, a Novel Peroxisome Proliferator-Activated Receptor γ Agonist, Attenuates Renal Fibrosis Caused by Unilateral Ureteral Obstruction in Mice
  Kwi-Hyun Bae, Jung Beom Seo, Yun-A Jung, Hye-Young Seo, Sun Hee Kang, Hui-Jeon Jeon, Jae Man Lee, Sungwoo Lee, Jung-Guk Kim, In-Kyu Lee, Gwon-Soo Jung, Keun-Gyu Park
  Endocrinology and Metabolism.2017; 32(1): 115.     CrossRef
• Gemigliptin: An Update of Its Clinical Use in the Management of Type 2 Diabetes Mellitus
  Sung-Ho Kim, Jung-Hwa Yoo, Woo Je Lee, Cheol-Young Park
  Diabetes & Metabolism Journal.2016; 40(5): 339.     CrossRef
• Risk assessment and management of post-transplant diabetes mellitus
  Eugene Han, Myoung Soo Kim, Yu Seun Kim, Eun Seok Kang
  Metabolism.2016; 65(10): 1559.     CrossRef

Citations

Citations to this article as recorded by  

• Proteomic Profiling of Extracellular Vesicles Isolated from Plasma and Peritoneal Exudate in Mice Induced by Crotalus scutulatus scutulatus Crude Venom and Its Purified Cysteine-Rich Secretory Protein (Css-CRiSP)
  Armando Reyes, Joseph D. Hatcher, Emelyn Salazar, Jacob Galan, Anton Iliuk, Elda E. Sanchez, Montamas Suntravat
  Toxins.2023; 15(7): 434.     CrossRef
• ApoA2–256T > C polymorphism interacts with Healthy Eating Index, Dietary Quality Index-International and Dietary Phytochemical Index to affect biochemical markers among type 2 diabetic patients
  Zahra Esmaeily, Gity Sotoudeh, Masoumeh Rafiee, Fariba Koohdani
  British Journal of Nutrition.2022; 127(9): 1343.     CrossRef
• Interaction between Apo A-II –265T > C polymorphism and dietary total antioxidant capacity on some oxidative stress and inflammatory markers in patients with type 2 diabetes mellitus
  Banafsheh Jafari Azad, Mehdi Yaseri, Elnaz Daneshzad, Fariba Koohdani
  British Journal of Nutrition.2022; 128(1): 13.     CrossRef
• Deletion allele of Apo B gene is associated with higher inflammation, oxidative stress and dyslipidemia in obese type 2 diabetic patients: an analytical cross-sectional study
  Nasim Mokhtary, Seyedeh Neda Mousavi, Gity Sotoudeh, Mostafa Qorbani, Maryam Dehghani, Fariba Koohdani
  BMC Endocrine Disorders.2022;[Epub]     CrossRef
• Interaction between Apo A-II -265T>C polymorphism and dietary total antioxidant capacity on some anthropometric indices and serum lipid profile in patients with type 2 diabetes mellitus
  Banafsheh Jafari Azad, Mehdi Yaseri, Elnaz Daneshzad, Fariba Koohdani
  Journal of Nutritional Science.2021;[Epub]     CrossRef
• A personalised diet study: The interaction between ApoA2 −265T > C polymorphism and dietary inflammatory index on oxidative and inflammatory markers and lipid profile in patients with type 2 diabetes mellitus: A cross‐sectional study
  Elmira Karimi, Pourya Tondkar, Gity Sotoudeh, Mostafa Qorbani, Masoumeh Rafiee, Fariba Koohdani
  International Journal of Clinical Practice.2021;[Epub]     CrossRef
• Interaction between the dietary indices and PPAR‐γ Pro12Ala gene variants on cardiovascular risk factors in patients with type 2 diabetes mellitus
  Faezeh Abaj, Gity Sotoudeh, Elmira Karimi, Masoumeh Rafiee, Fariba Koohdani
  International Journal of Clinical Practice.2021;[Epub]     CrossRef
• A Genetic Score of Predisposition to Low-Grade Inflammation Associated with Obesity May Contribute to Discern Population at Risk for Metabolic Syndrome
  Sebastià Galmés, Margalida Cifre, Andreu Palou, Paula Oliver, Francisca Serra
  Nutrients.2019; 11(2): 298.     CrossRef
• Study of the relationship between APOA-II −265T>C polymorphism and HDL function in response to weight loss in overweight and obese type 2 diabetic patients
  Masoumeh Moradi, Maryam Mahmoudi, Ahmad Saedisomeolia, Mohammad Ali Mansournia, Roxana Zahirihashemi, Fariba Koohdani
  Clinical Nutrition.2018; 37(3): 965.     CrossRef
• Apolipoprotein A-II induces acute-phase response associated AA amyloidosis in mice through conformational changes of plasma lipoprotein structure
  Mu Yang, Yingye Liu, Jian Dai, Lin Li, Xin Ding, Zhe Xu, Masayuki Mori, Hiroki Miyahara, Jinko Sawashita, Keiichi Higuchi
  Scientific Reports.2018;[Epub]     CrossRef
• Prenatal Exposure to Lipopolysaccharide Induces PTX3 Expression and Results in Obesity in Mouse Offspring
  Shugang Qin, Xin Chen, Meng Gao, Jianzhi Zhou, Xiaohui Li
  Inflammation.2017; 40(6): 1847.     CrossRef

Citations

Citations to this article as recorded by  

• Factors contributing to the adverse drug reactions associated with the dipeptidyl peptidase-4 (DPP-4) inhibitors: A scoping review
  Swetha R. Reghunath, Muhammed Rashid, Viji Pulikkel Chandran, Girish Thunga, K.N. Shivashankar, Leelavathi D. Acharya
  Diabetes & Metabolic Syndrome: Clinical Research & Reviews.2023; 17(7): 102790.     CrossRef
• Efficacy and safety of evogliptin in patients with type 2 diabetes and non‐alcoholic fatty liver disease: A multicentre, double‐blind, randomized, comparative trial
  Eugene Han, Ji Hye Huh, Eun Y. Lee, Ji C. Bae, Sung W. Chun, Sung H. Yu, Soo H. Kwak, Kyong S. Park, Byung‐Wan Lee
  Diabetes, Obesity and Metabolism.2022; 24(4): 752.     CrossRef
• A double‐blind, Randomized controlled trial on glucose‐lowering EFfects and safety of adding 0.25 or 0.5 mg lobeglitazone in type 2 diabetes patients with INadequate control on metformin and dipeptidyl peptidase‐4 inhibitor therapy: REFIND study
  Soree Ryang, Sang Soo Kim, Ji Cheol Bae, Ji Min Han, Su Kyoung Kwon, Young Il Kim, Il Seong Nam‐Goong, Eun Sook Kim, Mi‐kyung Kim, Chang Won Lee, Soyeon Yoo, Gwanpyo Koh, Min Jeong Kwon, Jeong Hyun Park, In Joo Kim
  Diabetes, Obesity and Metabolism.2022; 24(9): 1800.     CrossRef
• The rs12617336 and rs17574 Dipeptidyl Peptidase-4 Polymorphisms Are Associated With Hypoalphalipoproteinemia and Dipeptidyl Peptidase-4 Serum Levels: A Case-Control Study of the Genetics of Atherosclerotic Disease (GEA) Cohort
  Gilberto Vargas-Alarcón, María del Carmen González-Salazar, Christian Vázquez-Vázquez, Adrián Hernández-Díaz Couder, Fausto Sánchez-Muñoz, Juan Reyes-Barrera, Sergio A. Criales-Vera, Marco Sánchez-Guerra, Citlalli Osorio-Yáñez, Rosalinda Posadas-Sánchez
  Frontiers in Genetics.2021;[Epub]     CrossRef
• Reduction in HbA1c with SGLT2 inhibitors vs. DPP-4 inhibitors as add-ons to metformin monotherapy according to baseline HbA1c: A systematic review of randomized controlled trials
  A.J. Scheen
  Diabetes & Metabolism.2020; 46(3): 186.     CrossRef
• Combination Therapy of Oral Hypoglycemic Agents in Patients with Type 2 Diabetes Mellitus
  Min Kyong Moon
  The Journal of Korean Diabetes.2018; 19(1): 23.     CrossRef
• Comparative Cardiovascular Risks of Dipeptidyl Peptidase-4 Inhibitors: Analyses of Real-world Data in Korea
  Kyoung Hwa Ha, Bongseong Kim, Hae Sol Shin, Jinhee Lee, Hansol Choi, Hyeon Chang Kim, Dae Jung Kim
  Korean Circulation Journal.2018; 48(5): 395.     CrossRef
• Safety and efficacy of low dose pioglitazone compared with standard dose pioglitazone in type 2 diabetes with chronic kidney disease: A randomized controlled trial
  Bancha Satirapoj, Khanin Watanakijthavonkul, Ouppatham Supasyndh, Stephen L Atkin
  PLOS ONE.2018; 13(10): e0206722.     CrossRef
• Combination therapy of oral hypoglycemic agents in patients with type 2 diabetes mellitus
  Min Kyong Moon, Kyu Yeon Hur, Seung-Hyun Ko, Seok-O Park, Byung-Wan Lee, Jin Hwa Kim, Sang Youl Rhee, Hyun Jin Kim, Kyung Mook Choi, Nan-Hee Kim
  The Korean Journal of Internal Medicine.2017; 32(6): 974.     CrossRef
• Combination Therapy of Oral Hypoglycemic Agents in Patients with Type 2 Diabetes Mellitus
  Min Kyong Moon, Kyu-Yeon Hur, Seung-Hyun Ko, Seok-O Park, Byung-Wan Lee, Jin Hwa Kim, Sang Youl Rhee, Hyun Jin Kim, Kyung Mook Choi, Nan-Hee Kim
  Diabetes & Metabolism Journal.2017; 41(5): 357.     CrossRef
• Efficacy and safety of adding evogliptin versus sitagliptin for metformin‐treated patients with type 2 diabetes: A 24‐week randomized, controlled trial with open label extension
  Sang‐Mo Hong, Cheol‐Young Park, Dong‐Min Hwang, Kyung Ah Han, Chang Beom Lee, Choon Hee Chung, Kun‐Ho Yoon, Ji‐Oh Mok, Kyong Soo Park, Sung‐Woo Park
  Diabetes, Obesity and Metabolism.2017; 19(5): 654.     CrossRef
• Antihyperglycemic agent therapy for adult patients with type 2 diabetes mellitus 2017: a position statement of the Korean Diabetes Association
  Seung-Hyun Ko, Kyu-Yeon Hur, Sang Youl Rhee, Nan-Hee Kim, Min Kyong Moon, Seok-O Park, Byung-Wan Lee, Hyun Jin Kim, Kyung Mook Choi, Jin Hwa Kim
  The Korean Journal of Internal Medicine.2017; 32(6): 947.     CrossRef
• Antihyperglycemic Agent Therapy for Adult Patients with Type 2 Diabetes Mellitus 2017: A Position Statement of the Korean Diabetes Association
  Seung-Hyun Ko, Kyu-Yeon Hur, Sang Youl Rhee, Nan-Hee Kim, Min Kyong Moon, Seok-O Park, Byung-Wan Lee, Hyun Jin Kim, Kyung Mook Choi, Jin Hwa Kim
  Diabetes & Metabolism Journal.2017; 41(5): 337.     CrossRef

Citations

Citations to this article as recorded by  

• Effectiveness of Rebamipide as a part of the Helicobacter pylori eradication therapy in Russia: a meta-analysis of controlled trials
  Dmitry N. Andreev, Igor V. Maev, Dmitry S. Bordin, Svetlana V. Lyamina, Diana T. Dicheva, Aleksei K. Fomenko, Armine S. Bagdasarian
  Consilium Medicum.2022; 24(5): 333.     CrossRef
• Сompliance in patients with coronary heart disease and erosive-ulcerative gastroduodenopathy
  A. R. Molchanova, A. I. Dolgushina, A. A. Seljanina
  Experimental and Clinical Gastroenterology.2020; (6): 82.     CrossRef
• Rebamipide: evidence base for use in gastroenterology
  D. N. Andreev, I. V. Maev
  Terapevticheskii arkhiv.2020; 92(12): 97.     CrossRef
• Efficacy of Rebamipide in Organic and Functional Dyspepsia: A Systematic Review and Meta-Analysis
  Mohamed Hasif Jaafar, Sher Zaman Safi, Maw-Pin Tan, Sanjay Rampal, Sanjiv Mahadeva
  Digestive Diseases and Sciences.2018; 63(5): 1250.     CrossRef
• Letter: Effects of Rebamipide on Gastrointestinal Symptoms in Patients with Type 2 Diabetes Mellitus (Diabetes Metab J2016;40:240-7)
  Jin Hwa Kim
  Diabetes & Metabolism Journal.2016; 40(4): 334.     CrossRef
• Response: Effects of Rebamipide on Gastrointestinal Symptoms in Patients with Type 2 Diabetes Mellitus (Diabetes Metab J 2016;40:240-7)
  Sejeong Park, So Young Park, Sang Youl Rhee
  Diabetes & Metabolism Journal.2016; 40(4): 336.     CrossRef

Citations

Citations to this article as recorded by  

• Muscle Quality in Older Adults: A Scoping Review
  Charles Phillipe de Lucena Alves, Samuel Brito de Almeida, Danielle Pessoa Lima, Pedro Braga Neto, Ana Lúcia Miranda, Todd Manini, Lara Vlietstra, Debra L. Waters, Renata Moraes Bielemann, Rosaly Correa-de-Araujo, Ana Paula Fayh, Eduardo Caldas Costa
  Journal of the American Medical Directors Association.2023; 24(4): 462.     CrossRef
• Neuromuscular dysfunction and exercise training in people with diabetic peripheral neuropathy: A narrative review
  Giorgio Orlando, Stefano Balducci, Andrew J.M. Boulton, Hans Degens, Neil D. Reeves
  Diabetes Research and Clinical Practice.2022; 183: 109183.     CrossRef
• DPP4 inhibitors as a potential therapeutic option for sarcopenia: A 6-month follow-up study in diabetic older patients
  Canberk Sencan, Fatma Sena Dost, Esra Ates Bulut, Ahmet Turan Isik
  Experimental Gerontology.2022; 164: 111832.     CrossRef
• Níveis glicêmicos e sarcopenia em idosos com diabetes mellitus do tipo 2
  Isabella Stoeterau, Deise Regina Baptista, Andrea Pires Muller, Juliana Ceronato, Magda Rosa Ramos da Cruz, Carla Viana Dendasck
  Revista Científica Multidisciplinar Núcleo do Conhecimento.2022; : 53.     CrossRef